Active, Not Recruiting
Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment
NCT07565948
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- Xiangya Hospital of Central South University Changsha, Hunan, China